Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic small molecule belonging to the pyrrolopyridine and pyrimidinamine chemical classes. It features a propoxy group at the 4-position of a fused pyrrole–pyridine ring system and a pyrimidine amine moiety. The compound is primarily referenced in chemical and pharmacological databases as an experimental or research tool compound. Its precise mechanism of action is not fully characterized in public sources; however, it has been described as an inhibitor with potential activity against certain biological targets (such as kinases or phosphodiesterases), but no specific target or clinical indication is established. No approved therapeutic use or marketed product exists for this molecule at present[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine.